A Review of the Implementation of the Embryonic Stem Cell Test (EST)

Anon. (2006). RIP: Technical Guidance Documents (TGD). Available at: http://ecb.jrc.it/reach/rip (Accessed 14.05.09).

van der Jagt K. , Munn S. , Toersloev J. & de Bruijn J. (2004). Alternative Approaches Can Reduce the Use of Test Animals under REACH, 31 pp. Ispra, VA, Italy: European Commission Joint Research Centre, Institute for Health and Consumer Protection. Available at: ecb.jrc.ec.europa.eu/documents/REACH/PUBLICATIONS/Reducing_the_use_of_test_animals_under_REACH_IHCP_report.pdf (Accessed 14.05.09).

Cooper R.L. , Lamb J.C. , Barlow S.M. , Bentley K. , Brady A.M. , Doerrer N.G. , Eisenbrandt D.L. , Fenner-Crisp P.A. , Hines R.N. , Irvine L.F. , Kimmel C.A. , Koeter H. , Li A.A. , Makris S.L. , Sheets L.P. , Speijers G. & Whitby K.E. (2006). A tiered approach to life stages testing for agricultural chemical safety assessment. Critical Reviews in Toxicology 36, 69–98.

Hareng L. , Pellizzer C. , Bremer S. , Schwarz M. & Hartung T. (2005). The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Reproductive Toxicology 20, 441–452.

Genschow E. , Spielmann H. , Scholz G. , Pohl I. , Seiler A. , Clemann N. , Bremer S. & Becker K. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209–244.

Spielmann H. , Pohl I. , Döring B. , Liebsch M. & Moldenhauer F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. Toxicology in Vitro 10, 119–127.

Scholz G. , Pohl I. , Genschow E. , Klemm M. & Spielmann H. (1999). Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 165, 203–211.

Seiler A.E. , Buesen R. , Visan A. & Spielmann H. (2006). Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods in Molecular Biology 329, 371–395.

Balls M. & Hellsten E. (2002). Statement of the scientific validity of the embryonic stem cell test (EST) — an in vitro test for embryotoxicity. Statement of the scientific validity of the micromass test — an in vitro test for embryotoxicity. Statement of the scientific validity of the postimplantation rat whole embryo culture assay — an in vitro test for embryotoxicity. In ECVAM News and Views. ATLA 30, 265–273.

Paquette J.A. , Kumpf S.W. , Streck R.D. , Thomson J.J. , Chapin R.E. & Stedman D.B. (2008). Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Research Part B: Developmental & Reproductive Toxicology 83, 104–111.

Chapin R. , Stedman D. , Paquette J. , Streck R. , Kumpf S. & Deng S. (2007). Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicology in Vitro 21, 1545–1551.

Spielmann H. , Seiler A. , Bremer S. , Hareng L. , Hartung T. , Ahr H. , Faustman E. , Haas U. , Moffat G.J. , Nau H. , Vanparys P. , Piersma A. , Sintes J.R. & Stuart J. (2006). The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM Workshop 57). ATLA 34, 527–538.

Brown N.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 30, 177–198.

zur Nieden N.I. , Kempka G. & Ahr H.J. (2004). Molecular multiple endpoint embryonic stem cell test — a possible approach to test for the teratogenic potential of compounds. Toxicology & Applied Pharmacology 194, 257–269.

zur Nieden N.I. , Ruf L.J. , Kempka G. , Hildebrand H. & Ahr H.J. (2001). Molecular markers in embryonic stem cells. Toxicology in Vitro 15, 455–461.

Klemm M. & Schrattenholz A. (2004). Neurotoxicity of active compounds — establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification. ALTEX 21, Suppl. 3, 41–48.

Seiler A. , Visan A. , Buesen R. , Genschow E. & Spielmann H. (2004). Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reproductive Toxicology 18, 231–240.

Buesen R. , Genschow E. , Slawik B. , Visan A. , Spielmann H. , Luch A. & Seiler A. (2009). Embryonic stem cell test (EST) remastered: comparison between the validated EST and the new molecular FACS–EST for assessing developmental toxicity in vitro. Toxicological Sciences 108, 389–400.

Kaltenhaeuser J. , Genschow E. & Becker F. (2004). Quantitative gene expression analysis in mouse embryonic stem cells as an indicator of embryotoxic potential. Reproductive Toxicology 18, 707–757.

Buesen R. , Visan A. , Genschow E. , Slawik B. , Spielmann H. & Seiler A. (2004). Trends in improving the embryonic stem cell test (EST): an overview. ALTEX 21, 15–22.

Seiler A. , Buesen R. , Hayess K. , Schlechter K. , Visan A. , Genschow E. , Slawik B. & Spielmann H. (2006). Current status of the embryonic stem cell test: the use of recent advances in the field of stem cell technology and gene expression analysis. ALTEX 23, 393–399.

Peters A.K. , Steemans M. , Hansen E. , Mesens N. , Verheyen G.R. & Vanparys P. (2008). Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test. Toxicological Sciences 105, 342–350.

Peters A.K. , Wouwer G.V. , Weyn B. , Verheyen G.R. , Vanparys P. & Gompel J.V. (2008). Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicology in Vitro 22, 1948–1956.